Texaf S.A.
Texaf S.A. develops, owns, and leases real estate properties in the Democratic Republic of Congo. It operates through Real Estate, Digital, and Quarries segments. The company's portfolio comprises 426 homes, including 53 villas and 373 flats with a residential area of 82,200 square meters; 26,300 square meters of office and retail premises; and 30,000 square meters of warehouses, as well as the T… Read more
Texaf S.A. (0Q5Q) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, Texaf S.A. (0Q5Q) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Texaf S.A. - Net Assets Trend (None–None)
This chart illustrates how Texaf S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Texaf S.A. (None–None)
The table below shows the annual net assets of Texaf S.A. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Texaf S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Texaf S.A. Competitors by Market Cap
The table below lists competitors of Texaf S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Perfect Corp.
NYSE:PERF
|
$39.41 Million |
|
Dynamic Medical Technologies
TWO:4138
|
$39.41 Million |
|
EgnsINVEST Ejendomme Tyskland A/S
CO:EGNETY
|
$39.41 Million |
|
E3 Metals Corp
OTCQX:EEMMF
|
$39.42 Million |
|
INFOM
KLSE:0265
|
$39.41 Million |
|
Punjab Chemicals & Crop Protection Limited
NSE:PUNJABCHEM
|
$39.40 Million |
|
AGAGF
PINK:AGAGF
|
$39.40 Million |
|
Susco Public Company Limited
BK:SUSCO
|
$39.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Texaf S.A.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Texaf S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Texaf S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Texaf S.A.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Texaf S.A. (0Q5Q) | €- | N/A | N/A | $39.41 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |